You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer
|
|---|---|
| Published in |
The Lancet, October 1997
|
| DOI | 10.1016/s0140-6736(97)08233-0 |
| Pubmed ID | |
| Authors |
Collaborative Group on Hormonal Factors in Breast Cancer |
| Abstract |
The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed about 90% of the worldwide epidemiological evidence on the relation between risk of breast cancer and use of hormone replacement therapy (HRT). |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Netherlands | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 594 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | <1% |
| Denmark | 2 | <1% |
| Netherlands | 1 | <1% |
| France | 1 | <1% |
| Colombia | 1 | <1% |
| Turkey | 1 | <1% |
| Egypt | 1 | <1% |
| South Africa | 1 | <1% |
| Brazil | 1 | <1% |
| Other | 4 | <1% |
| Unknown | 578 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 97 | 16% |
| Student > Ph. D. Student | 80 | 13% |
| Researcher | 60 | 10% |
| Student > Bachelor | 58 | 10% |
| Student > Doctoral Student | 35 | 6% |
| Other | 125 | 21% |
| Unknown | 139 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 197 | 33% |
| Agricultural and Biological Sciences | 57 | 10% |
| Biochemistry, Genetics and Molecular Biology | 55 | 9% |
| Nursing and Health Professions | 23 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 3% |
| Other | 80 | 13% |
| Unknown | 162 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2024.
All research outputs
#1,609,008
of 25,768,270 outputs
Outputs from The Lancet
#10,891
of 42,993 outputs
Outputs of similar age
#582
of 29,234 outputs
Outputs of similar age from The Lancet
#12
of 154 outputs
Altmetric has tracked 25,768,270 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 42,993 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 29,234 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 154 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.